AZYTER

This brand name is authorized in Austria, Croatia, Cyprus, Finland, France, Hong Kong SAR China, Ireland, Netherlands, Poland, Romania, Tunisia, Turkey, UK.

Active ingredients

The drug AZYTER contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AA26	Azithromycin	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	400839
FR	Base de données publique des médicaments	69326767
GB	Medicines & Healthcare Products Regulatory Agency	193724
HK	Department of Health Drug Office	60515
HR	Agencija za lijekove i medicinske proizvode	HR-H-422626992
IE	Health Products Regulatory Authority	13113
NL	Z-Index G-Standaard, PRK	86975
PL	Rejestru Produktów Leczniczych	100181487
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W56936001
TN	Direction de la Pharmacie et du Médicament	8443081
TR	İlaç ve Tıbbi Cihaz Kurumu	8680177220054